{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:23:14Z","timestamp":1791404594814,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370184"],"award-info":[{"award-number":["82370184"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20231220"],"award-info":[{"award-number":["BK20231220"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Suzhou Municipal Key Laboratory","award":["SZS2022005"],"award-info":[{"award-number":["SZS2022005"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-1-024, 2022-I2M-2-004"],"award-info":[{"award-number":["2022-I2M-1-024, 2022-I2M-2-004"]}]},{"name":"the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2022-RC180-02"],"award-info":[{"award-number":["2022-RC180-02"]}]},{"name":"the Special Research Fund for Central Universities, Peking Union Medical College","award":["3332023082"],"award-info":[{"award-number":["3332023082"]}]},{"name":"The NCTIB Fund for R&D Platform for Cell and Gene Therapy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17288-4","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:33:30Z","timestamp":1756312410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Signature of leukemia stem cell death pattern predicts prognosis and therapeutic response of acute myeloid leukemia patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Fuqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"17288_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N. Engl. J. Med. 373, 1136\u20131152. https:\/\/doi.org\/10.1056\/NEJMra1406184 (2015).","journal-title":"N. Engl. J. Med."},{"key":"17288_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 98, 502\u2013526. https:\/\/doi.org\/10.1002\/ajh.26822 (2023).","journal-title":"Am. J. Hematol."},{"key":"17288_CR3","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/S2352-3026(22)00106-5","volume":"9","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Venetoclax plus 3\u2009+\u20097 Daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 9, e415\u2013e424. https:\/\/doi.org\/10.1016\/S2352-3026(22)00106-5 (2022).","journal-title":"Lancet Haematol."},{"key":"17288_CR4","doi-asserted-by":"publisher","unstructured":"Liu, H. Emerging agents and regimens for AML. J. Hematol. Oncol. 14 https:\/\/doi.org\/10.1186\/s13045-021-01062-w (2021).","DOI":"10.1186\/s13045-021-01062-w"},{"key":"17288_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202\u2013208. https:\/\/doi.org\/10.1038\/nm.3048 (2013).","journal-title":"Nat. Med."},{"key":"17288_CR6","doi-asserted-by":"publisher","first-page":"775128","DOI":"10.3389\/fimmu.2021.775128","volume":"12","author":"T Marchand","year":"2021","unstructured":"Marchand, T. & Pinho, S. Leukemic stem cells: from leukemic niche biology to treatment opportunities. Front. Immunol. 12, 775128. https:\/\/doi.org\/10.3389\/fimmu.2021.775128 (2021).","journal-title":"Front. Immunol."},{"key":"17288_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41467-024-45691-4","volume":"15","author":"SG Kellaway","year":"2024","unstructured":"Kellaway, S. G. et al. Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth. Nat. Commun. 15, 1359. https:\/\/doi.org\/10.1038\/s41467-024-45691-4 (2024).","journal-title":"Nat. Commun."},{"key":"17288_CR8","doi-asserted-by":"publisher","first-page":"103710","DOI":"10.1016\/j.critrevonc.2022.103710","volume":"175","author":"SK Khaldoyanidi","year":"2022","unstructured":"Khaldoyanidi, S. K., Hindoyan, A., Stein, A. & Subklewe, M. Leukemic stem cells as a target for eliminating acute myeloid leukemia: gaps in translational research. Crit. Rev. Oncol. Hematol. 175, 103710. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103710 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"17288_CR9","doi-asserted-by":"publisher","first-page":"931050","DOI":"10.3389\/fonc.2022.931050","volume":"12","author":"IV Barreto","year":"2022","unstructured":"Barreto, I. V. et al. Leukemic stem cell: A Mini-Review on clinical perspectives. Front. Oncol. 12, 931050. https:\/\/doi.org\/10.3389\/fonc.2022.931050 (2022).","journal-title":"Front. Oncol."},{"key":"17288_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","volume":"10","author":"S Pei","year":"2020","unstructured":"Pei, S. et al. Monocytic subclones confer resistance to Venetoclax-Based therapy in patients with acute myeloid leukemia. Cancer Discov. 10, 536\u2013551. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0710 (2020).","journal-title":"Cancer Discov"},{"key":"17288_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10495-021-01682-0","volume":"26","author":"X Dai","year":"2021","unstructured":"Dai, X., Wang, D. & Zhang, J. Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis 26, 385\u2013414. https:\/\/doi.org\/10.1007\/s10495-021-01682-0 (2021).","journal-title":"Apoptosis"},{"key":"17288_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41419-024-06712-8","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Li, X., Yang, M. & Liu, S. B. Research progress on morphology and mechanism of programmed cell death. Cell. Death Dis. 15, 327. https:\/\/doi.org\/10.1038\/s41419-024-06712-8 (2024).","journal-title":"Cell. Death Dis."},{"key":"17288_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41698-024-00570-5","volume":"8","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response. NPJ Precis Oncol. 8, 77. https:\/\/doi.org\/10.1038\/s41698-024-00570-5 (2024).","journal-title":"NPJ Precis Oncol."},{"key":"17288_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell. Death Differ. 25, 486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4 (2018).","journal-title":"Cell. Death Differ."},{"key":"17288_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"17288_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-021-01076-4","volume":"14","author":"R Buettner","year":"2021","unstructured":"Buettner, R. et al. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine. J. Hematol. Oncol. 14, 70. https:\/\/doi.org\/10.1186\/s13045-021-01076-4 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"17288_CR17","doi-asserted-by":"publisher","unstructured":"van Galen, P. et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell 176, 1265\u20131281 e1224, (2019). https:\/\/doi.org\/10.1016\/j.cell.2019.01.031","DOI":"10.1016\/j.cell.2019.01.031"},{"key":"17288_CR18","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","volume":"28","author":"AGX Zeng","year":"2022","unstructured":"Zeng, A. G. X. et al. A cellular hierarchy framework for Understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat. Med. 28, 1212\u20131223. https:\/\/doi.org\/10.1038\/s41591-022-01819-x (2022).","journal-title":"Nat. Med."},{"key":"17288_CR19","doi-asserted-by":"publisher","unstructured":"Shi, K. et al. Bone marrow hematopoiesis drives multiple sclerosis progression. Cell 185, 2234\u20132247 e2217, (2022). https:\/\/doi.org\/10.1016\/j.cell.2022.05.020","DOI":"10.1016\/j.cell.2022.05.020"},{"key":"17288_CR20","doi-asserted-by":"publisher","unstructured":"Kim, D. D. H. et al. The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia. EJHaem 3, 873\u2013884, (2022). https:\/\/doi.org\/10.1002\/jha2.466","DOI":"10.1002\/jha2.466"},{"key":"17288_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su, Z., Yang, Z., Xu, Y., Chen, Y. & Yu, Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol. Cancer. 14, 48. https:\/\/doi.org\/10.1186\/s12943-015-0321-5 (2015).","journal-title":"Mol. Cancer"},{"key":"17288_CR22","first-page":"3945","volume":"63","author":"LY Fong","year":"2003","unstructured":"Fong, L. Y., Feith, D. J. & Pegg, A. E. Antizyme overexpression in Transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res. 63, 3945\u20133954 (2003).","journal-title":"Cancer Res."},{"key":"17288_CR23","doi-asserted-by":"publisher","unstructured":"Padella, A. et al. Novel and rare fusion transcripts involving transcription factors and tumor suppressor genes in acute myeloid leukemia. Cancers (Basel). 11 https:\/\/doi.org\/10.3390\/cancers11121951 (2019).","DOI":"10.3390\/cancers11121951"},{"key":"17288_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41375-019-0596-4","volume":"34","author":"B Alanazi","year":"2020","unstructured":"Alanazi, B. et al. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34, 427\u2013440. https:\/\/doi.org\/10.1038\/s41375-019-0596-4 (2020).","journal-title":"Leukemia"},{"key":"17288_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s10020-024-00861-4","volume":"30","author":"X Tan","year":"2024","unstructured":"Tan, X. et al. The dual role of FSP1 in programmed cell death: resisting ferroptosis in the cell membrane and promoting necroptosis in the nucleus of THP-1 cells. Mol. Med. 30, 102. https:\/\/doi.org\/10.1186\/s10020-024-00861-4 (2024).","journal-title":"Mol. Med."},{"key":"17288_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1172\/JCI59334","volume":"122","author":"S Agnihotri","year":"2012","unstructured":"Agnihotri, S. et al. Alkylpurine-DNA-N-glycosylase confers resistance to Temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. J. Clin. Invest. 122, 253\u2013266. https:\/\/doi.org\/10.1172\/JCI59334 (2012).","journal-title":"J. Clin. Invest."},{"key":"17288_CR27","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1158\/0008-5472.CAN-20-0531","volume":"80","author":"CH Nguyen","year":"2020","unstructured":"Nguyen, C. H. et al. IL2RA promotes aggressiveness and stem Cell-Related properties of acute myeloid leukemia. Cancer Res. 80, 4527\u20134539. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0531 (2020).","journal-title":"Cancer Res."},{"key":"17288_CR28","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1158\/1078-0432.CCR-14-2684","volume":"21","author":"GS Laszlo","year":"2015","unstructured":"Laszlo, G. S. et al. Multimerin-1 (MMRN1) as novel adverse marker in pediatric acute myeloid leukemia: A report from the children\u2019s oncology group. Clin. Cancer Res. 21, 3187\u20133195. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2684 (2015).","journal-title":"Clin. Cancer Res."},{"key":"17288_CR29","doi-asserted-by":"publisher","unstructured":"Uras, I. Z., Sexl, V. & Kollmann, K. CDK6 inhibition: A novel approach in AML management. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21072528 (2020).","DOI":"10.3390\/ijms21072528"},{"key":"17288_CR30","doi-asserted-by":"publisher","unstructured":"Uras, I. Z. et al. Palbociclib treatment of FLT3-ITD\u2009+\u2009AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6. Blood 127, 2890\u20132902, (2016). https:\/\/doi.org\/10.1182\/blood-2015-11-683581","DOI":"10.1182\/blood-2015-11-683581"},{"key":"17288_CR31","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.1038\/s41467-023-43264-5","volume":"14","author":"S Wright","year":"2023","unstructured":"Wright, S. et al. Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens. Nat. Commun. 14, 7464. https:\/\/doi.org\/10.1038\/s41467-023-43264-5 (2023).","journal-title":"Nat. Commun."},{"key":"17288_CR32","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1182\/bloodadvances.2018025866","volume":"2","author":"X Zhong","year":"2018","unstructured":"Zhong, X. et al. HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes. Blood Adv. 2, 3137\u20133148. https:\/\/doi.org\/10.1182\/bloodadvances.2018025866 (2018).","journal-title":"Blood Adv."},{"key":"17288_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/sj.leu.2403696","volume":"19","author":"N Pineault","year":"2005","unstructured":"Pineault, N., Abramovich, C. & Humphries, R. K. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA. Leukemia 19, 636\u2013643. https:\/\/doi.org\/10.1038\/sj.leu.2403696 (2005).","journal-title":"Leukemia"},{"key":"17288_CR34","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1172\/JCI129941","volume":"130","author":"MR Paul","year":"2020","unstructured":"Paul, M. R. et al. Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets. J. Clin. Invest. 130, 4252\u20134265. https:\/\/doi.org\/10.1172\/JCI129941 (2020).","journal-title":"J. Clin. Invest."},{"key":"17288_CR35","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1038\/s41467-020-18379-8","volume":"11","author":"H Guo","year":"2020","unstructured":"Guo, H. et al. Intercalated disc protein Xinbeta is required for Hippo-YAP signaling in the heart. Nat. Commun. 11, 4666. https:\/\/doi.org\/10.1038\/s41467-020-18379-8 (2020).","journal-title":"Nat. Commun."},{"key":"17288_CR36","doi-asserted-by":"publisher","unstructured":"Li, D. et al. Identification of clinical value and biological effects of XIRP2 mutation in hepatocellular carcinoma. Biology (Basel). 13. https:\/\/doi.org\/10.3390\/biology13080633 (2024).","DOI":"10.3390\/biology13080633"},{"key":"17288_CR37","doi-asserted-by":"publisher","first-page":"107780","DOI":"10.1016\/j.compbiomed.2023.107780","volume":"169","author":"Y Luo","year":"2024","unstructured":"Luo, Y., Liu, L. & Zhang, C. Identification and analysis of diverse cell death patterns in diabetic kidney disease using microarray-based transcriptome profiling and single-nucleus RNA sequencing. Comput. Biol. Med. 169, 107780. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107780 (2024).","journal-title":"Comput. Biol. Med."},{"key":"17288_CR38","doi-asserted-by":"publisher","first-page":"39098","DOI":"10.18632\/oncotarget.5390","volume":"6","author":"MK Chuang","year":"2015","unstructured":"Chuang, M. K. et al. An mRNA expression signature for prognostication in de Novo acute myeloid leukemia patients with normal karyotype. Oncotarget 6, 39098\u201339110. https:\/\/doi.org\/10.18632\/oncotarget.5390 (2015).","journal-title":"Oncotarget"},{"key":"17288_CR39","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41375-020-0839-4","volume":"34","author":"SA Bamopoulos","year":"2020","unstructured":"Bamopoulos, S. A. et al. Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia. Leukemia 34, 2621\u20132634. https:\/\/doi.org\/10.1038\/s41375-020-0839-4 (2020).","journal-title":"Leukemia"},{"key":"17288_CR40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531. https:\/\/doi.org\/10.1038\/s41586-018-0623-z (2018).","journal-title":"Nature"},{"key":"17288_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/bloodadvances.2019001124","volume":"4","author":"H Celik","year":"2020","unstructured":"Celik, H. et al. Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia. Blood Adv. 4, 367\u2013379. https:\/\/doi.org\/10.1182\/bloodadvances.2019001124 (2020).","journal-title":"Blood Adv."},{"key":"17288_CR42","doi-asserted-by":"publisher","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529, (2021). https:\/\/doi.org\/10.1016\/j.cell.2021.04.048","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"17288_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"17288_CR44","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb). 2, 100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141 (2021).","journal-title":"Innov. (Camb)"},{"key":"17288_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell. Syst."},{"key":"17288_CR46","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan, H. et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 47, D900\u2013D908. https:\/\/doi.org\/10.1093\/nar\/gky939 (2019).","journal-title":"Nucleic Acids Res."},{"key":"17288_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","volume":"58","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya, S. et al. ImmPort: disseminating data to the public for the future of immunology. Immunol. Res. 58, 234\u2013239. https:\/\/doi.org\/10.1007\/s12026-014-8516-1 (2014).","journal-title":"Immunol. Res."},{"key":"17288_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1\u201326. https:\/\/doi.org\/10.18637\/jss.v028.i05 (2008).","journal-title":"J. Stat. Softw."},{"key":"17288_CR49","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397. https:\/\/doi.org\/10.1002\/sim.5958 (2013).","journal-title":"Stat. Med."},{"key":"17288_CR50","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1 (2018).","journal-title":"Nat. Med."},{"key":"17288_CR51","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12, 453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337 (2015).","journal-title":"Nat. Methods"},{"key":"17288_CR52","doi-asserted-by":"publisher","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform. 22 https:\/\/doi.org\/10.1093\/bib\/bbab260 (2021).","DOI":"10.1093\/bib\/bbab260"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17288-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17288-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17288-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:33:31Z","timestamp":1756312411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17288-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17288"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17288-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31612"}}